RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재

    Iopamidol과 Ioversol 제제 조영제의 온도변화에 따른 물리화학적 분석 = Physicochemical Analysis according to Temperature Changes of Iopamidol and Ioversol Formulation Contrast Agents

    한글로보기

    https://www.riss.kr/link?id=A107016236

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    In this study, the P contrast agent of Iopamidol, which is a nonionic iodide contrast agent most commonly used as a vascular contrast agent in medical institutions, and the O contrast agent of Ioversol, were studied. The physicochemical changes according to the temperature change were compared and analyzed using the Bruker Avance 500MHz Nuclear Magnetic Resonance Spectrometer owned by the Korea Basic Science Institute (KBSI). There was no physical or chemical change in the O contrast medium of Ioversol formulation in temperature change. However, in the P contrast agent of Iopamidol, a doublet peak began to appear in the 1.1 ppm region of the sample at 60℃, and the doublet peak was clearly observed in the sample at 80℃. As a result of this study, 1H-NMR analysis revealed that the P contrast agent of the Iopamidol formulation was dissociated from chemical bonds as it rose to a high temperature of 60℃ or higher, resulting in the formation of foreign substances. It was evaluated that the O contrast agent of Ioversol formulation had physico-chemical stability than the P contrast agent of Iopamidol formulation. As shown in this study, it is necessary to analyze the physical and chemical changes of contrast agents according to various environmental factors.
    번역하기

    In this study, the P contrast agent of Iopamidol, which is a nonionic iodide contrast agent most commonly used as a vascular contrast agent in medical institutions, and the O contrast agent of Ioversol, were studied. The physicochemical changes accord...

    In this study, the P contrast agent of Iopamidol, which is a nonionic iodide contrast agent most commonly used as a vascular contrast agent in medical institutions, and the O contrast agent of Ioversol, were studied. The physicochemical changes according to the temperature change were compared and analyzed using the Bruker Avance 500MHz Nuclear Magnetic Resonance Spectrometer owned by the Korea Basic Science Institute (KBSI). There was no physical or chemical change in the O contrast medium of Ioversol formulation in temperature change. However, in the P contrast agent of Iopamidol, a doublet peak began to appear in the 1.1 ppm region of the sample at 60℃, and the doublet peak was clearly observed in the sample at 80℃. As a result of this study, 1H-NMR analysis revealed that the P contrast agent of the Iopamidol formulation was dissociated from chemical bonds as it rose to a high temperature of 60℃ or higher, resulting in the formation of foreign substances. It was evaluated that the O contrast agent of Ioversol formulation had physico-chemical stability than the P contrast agent of Iopamidol formulation. As shown in this study, it is necessary to analyze the physical and chemical changes of contrast agents according to various environmental factors.

    더보기

    참고문헌 (Reference)

    1 권기수, "컴퓨터 단층촬영(Computed Tomography)에 사용되는 조영제의 부작용 발생에 대한 분석" 울산대학교 산업대학원 2004

    2 강영한, "조영제 부작용에 대한 주의의무와 제조물책임" 대한방사선과학회 30 (30): 305-311, 2007

    3 박창묵, "방사선 검사에 사용되는 조영제 Iopamidol의 안전성 평가" 대한약학회 53 (53): 328-333, 2009

    4 Smedby O, "Viscosity of some contemporary contrast media before and after mixing with whole blood" 33 : 600-605, 1992

    5 Siegle R, "The use of iohexol in patients with previous reactions to ionic contrast material" 26 : 411-416, 1991

    6 Thomas AMK, "The invisible light, 100 year of medical radiology" Blackwell Science 13-18, 1995

    7 Wallingford VH, "The development of organic iodide compounds as X-ray contrast media" 42 : 721-728, 1953

    8 Lee SK, "The analysis of NMR spectrum" Hanrimwon 2014

    9 Dawson P, "Textbook contrast media" British Library 1999

    10 Ko IH, "Textbook computed tomography" Chung-Ku Publisher 2005

    1 권기수, "컴퓨터 단층촬영(Computed Tomography)에 사용되는 조영제의 부작용 발생에 대한 분석" 울산대학교 산업대학원 2004

    2 강영한, "조영제 부작용에 대한 주의의무와 제조물책임" 대한방사선과학회 30 (30): 305-311, 2007

    3 박창묵, "방사선 검사에 사용되는 조영제 Iopamidol의 안전성 평가" 대한약학회 53 (53): 328-333, 2009

    4 Smedby O, "Viscosity of some contemporary contrast media before and after mixing with whole blood" 33 : 600-605, 1992

    5 Siegle R, "The use of iohexol in patients with previous reactions to ionic contrast material" 26 : 411-416, 1991

    6 Thomas AMK, "The invisible light, 100 year of medical radiology" Blackwell Science 13-18, 1995

    7 Wallingford VH, "The development of organic iodide compounds as X-ray contrast media" 42 : 721-728, 1953

    8 Lee SK, "The analysis of NMR spectrum" Hanrimwon 2014

    9 Dawson P, "Textbook contrast media" British Library 1999

    10 Ko IH, "Textbook computed tomography" Chung-Ku Publisher 2005

    11 Dyvik K, "Relationship between viscosity and determined injection pressure in angio-graphic catheters for common roentgen contrast media" 36 : 43-49, 1995

    12 Swick M, "Radiographic media in urology, the discovery of excretion urography" 58 : 977-994, 1978

    13 "Ministry of Food and Drug Safety"

    14 양원석, "MDCT에 사용되는 조영제의 부작용에 대한 고찰" 대한방사선과학회 35 (35): 51-57, 2012

    15 Von Lichtenberg A, "Klinische Prüfung des Uroselectans" 8 : 2089-2091, 1929

    16 ESUR Contrast Media Safety Committee, "ESUR guidelines on contrast media"

    17 "Dongkook Life Science"

    18 Swick M, "Darstellung der Niere und Harnwege in Roentgenbild durch intravenose Einbringung eines Kontraststoffes : Des Uroselectans" 8 : 2087-2089, 1929

    19 Almén T, "Contrast agent design. Some aspects on the synthesis of water-soluble contrast agents of low osmolality" 24 : 216-226, 1969

    20 Hyun-Sook Hong, "Clinical Application of Intravascular Administration of Non-ionic, Low Osmolar Contrast Agent, Ioversol(Optiray 320)and Its Side Effects Comparison with Meglumine Iothalamate(Conray 60)" 26 (26): 1284-1290, 1990

    21 김영덕, "CT조영검사에서 조영제 부작용의 실태와 관련요인 조사" 전남대학교 대학원 2005

    22 권대철, "CT 조영제의 부작용 예방을 위한 표준진료지침서의 개발과 적용" 대한방사선과학회 30 (30): 39-46, 2007

    23 Wieten DM, "Acute reaction to urographic contrast medium : Incidence, clinical characteristics and relationships to hypersensitivity states" 119 : 832-840, 1973

    24 Kyung Eun Jung, "A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea" 대한피부과학회 24 (24): 22-25, 2012

    더보기

    동일학술지(권/호) 다른 논문

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 재인증평가 신청대상 (재인증)
    2020-01-01 등재 등재학술지 선정 (재인증) KCI등재
    2019-01-01 등재 등재후보학술지 유지 (계속평가) KCI등재후보
    2018-12-01 등재 등재후보로 하락 (계속평가) KCI등재후보
    2015-01-01 등재 등재학술지 선정 (계속평가) KCI등재
    2013-01-01 등재 등재후보학술지 유지 (기타) KCI등재후보
    2012-01-01 등재 등재후보학술지 유지 (기타) KCI등재후보
    2011-01-01 등재 등재후보 1차 PASS (등재후보1차) KCI등재후보
    2010-01-01 등재 등재후보 1차 FAIL (등재후보1차) KCI등재후보
    2009-01-01 등재 등재후보학술지 유지 (등재후보2차) KCI등재후보
    2008-01-01 등재 등재후보 1차 PASS (등재후보1차) KCI등재후보
    2007-05-08 학회명변경 한글명 : 대한방사선기술학회 -> 대한방사선과학회
    영문명 : Korean Society Of Radiologial Technology -> Korean Society of Radiological Science
    KCI등재후보
    2006-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.37 0.37 0.38
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.4 0.41 0.487 0.08
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼